- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03160690
Changes in Choroidal Thickness After Non Penetrating Deep Sclerectomy
May 18, 2017 updated by: Sandra Gómez Sánchez, Germans Trias i Pujol Hospital
Prospective and observational study to determine if choroidal thickness increases after non penetrating deep sclerectomy in patients with open angle glaucoma
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Barcelona
-
Badalona, Barcelona, Spain, 08916
- Germans Trias i Pujol Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with progressive open angle glaucoma although topical treatment with indication for non penetrating deep sclerectomy
Description
Inclusion Criteria:
- Progressive Primary Open Angle Glaucoma
Exclusion Criteria:
- Age under 18yrs
- Myopia or Hyperopia higher than -6D or +6D
- Secondary glaucoma
- Ocular surgery other than cataract
- Other ocular pathology
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Choroidal thickness
Time Frame: before and 1 week, 1 month, 3 months and 6 months after non penetrating deep sclerectomy
|
Choroidal thickness measured by optic coherence tomography
|
before and 1 week, 1 month, 3 months and 6 months after non penetrating deep sclerectomy
|
|
Change in Intraocular pressure
Time Frame: before and 1 week, 1 month, 3 months and 6 months after non penetrating deep sclerectomy
|
mmHg
|
before and 1 week, 1 month, 3 months and 6 months after non penetrating deep sclerectomy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sandra Gómez Sánchez, MD, Germans Trias i Pujol Hospital
- Principal Investigator: Pau Romera Romero, MD, Germans Trias i Pujol Hospital
- Principal Investigator: Jorge Loscos Arenas, PhD, Germans Trias i Pujol Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
June 17, 2017
Primary Completion (ANTICIPATED)
November 17, 2017
Study Completion (ANTICIPATED)
May 17, 2018
Study Registration Dates
First Submitted
May 17, 2017
First Submitted That Met QC Criteria
May 18, 2017
First Posted (ACTUAL)
May 19, 2017
Study Record Updates
Last Update Posted (ACTUAL)
May 19, 2017
Last Update Submitted That Met QC Criteria
May 18, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OFT-ENP-2017-03
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Open Angle Glaucoma
-
Henry Ford Health SystemNot yet recruitingPrimary Open Angle Glaucoma (POAG) | Secondary Open Angle Glaucoma | Open Angle Glaucoma (OAG)United States
-
Glostrup University Hospital, CopenhagenRecruitingGlaucoma | Open-Angle Glaucoma | Primary Open Angle Glaucoma (POAG)Denmark
-
AllerganCompleted18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) (ARGOS)Ocular Hypertension | Open-angle GlaucomaUnited States
-
Sanoculis LtdActive, not recruitingOcular Hypertension | Glaucoma | Open-Angle GlaucomaArmenia
-
Asociación para Evitar la Ceguera en MéxicoTerminated
-
Aerie PharmaceuticalsCompletedOcular Hypertension | Open-angle Glaucoma
-
West Virginia UniversityUniversity of Pittsburgh; University of MichiganWithdrawnOpen-angle Glaucoma
-
Glaukos CorporationUnknownOpen-Angle GlaucomaSpain, Germany, Austria, Turkey
-
Alcon ResearchWithdrawnOpen-Angle Glaucoma
Clinical Trials on Non penetrating deep sclerectomy
-
Shahid Beheshti University of Medical SciencesActive, not recruitingGlaucoma | CataractIran, Islamic Republic of
-
Al-Azhar UniversityActive, not recruiting
-
King Saud UniversityUnknownCongenital GlaucomaSaudi Arabia
-
Institut Catala de RetinaHospital Universitario Ramon y Cajal; Hospital del Mar; Clinica Universidad de... and other collaboratorsCompletedOcular Hypertension | Open Angle GlaucomaSpain
-
Military Institute of Medicine, PolandUnknownCataract | Open Angle GlaucomaPoland
-
Germans Trias i Pujol HospitalRecruiting
-
Helsinki University Central HospitalRecruitingNormal Tension GlaucomaFinland
-
University of ParmaCompleted
-
Beni-Suef UniversityCompletedOpen Angle Glaucoma (OAG)Egypt